跳转至内容
Merck
CN
搜索范围
内容物类型
集合
产品分类
应用

CR0003L200MM

应用筛选条件
关键词:'CR0003L200MM'
facet content type:Technical Article
显示 1-10 #N/A 12 条结果 关于 "CR0003L200MM" 范围 网站内容
Bioreactor Process Development and Scale-Up for Transient Transfection-Based Lentivirus Manufacturing in Suspension Cell Culture
A step-by-step overview of suspension-based, transient transfection bioreactor process development and scaleup of lentivirus production.
Reproducible Scaling of a Cell Retention Filter Using the Cellicon® Cell Retention Solution
This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.
Seed Train Intensification Using High Cell Density Cryopreservation
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
Operational and Financial Advantages of Cellicon® Cell Retention Solution in an N-1 Perfusion Process
This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.
Cell Retention Technology and Specialized Cell Culture Media for Intensified Upstream Processing
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
Optimizing CHO Cells for Higher Productivity
Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.
Egg-based and Cell-based Influenza Vaccine Manufacturing Methods
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Developing and Manufacturing Attenuated Viral Vaccines
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
Building Regional Single-Use Supply Chains
Our global network of raw material suppliers and regional production sites for single-use technologies ensures business continuity for biopharma customers.
1/2